Empowered Patient Podcast with Karen Jagoda is a window into the latest innovations in digital health, the changing dynamic between doctors and patients, and the emergence of precision medicine. The show covers such topics as aging in place, innovative uses for wearables and sensors, advances in clinical research, applied genetics, drug development, and challenges for connected health entrepreneurs.
…
continue reading
Medicalapps Podcasts
1
AI Revolutionizing Drug Development Regulatory Documentation and FDA Submission with Lindsay Mateo Weave TRANSCRIPT
Lindsay Mateo is the Chief Commercial Officer at Weave. This company has developed a platform to automate and streamline the regulatory documentation process for FDA submission for pharmaceutical and biotech companies. The regulatory lifecycle for drug development currently involves data from various sources in digital and paper formats. Weave Bio'…
…
continue reading
1
AI Revolutionizing Drug Development Regulatory Documentation and FDA Submission with Lindsay Mateo Weave
19:09
19:09
Play later
Play later
Lists
Like
Liked
19:09
Lindsay Mateo is the Chief Commercial Officer at Weave. This company has developed a platform to automate and streamline the regulatory documentation process for FDA submission for pharmaceutical and biotech companies. The regulatory lifecycle for drug development currently involves data from various sources in digital and paper formats. Weave Bio'…
…
continue reading
1
Streamlining the Process for Accessing Medical Marijuana Cards with Aspen Noonan Elevate Holistics TRANSCRIPT
Aspen Noonan, CEO of Elevate Holistics, a company that helps patients obtain medical marijuana cards through a telehealth consultation with licensed doctors. The qualifications for obtaining a medical marijuana card vary by state, and Elevate Holistics helps patients navigate the regulatory landscape. Many doctors are hesitant to recommend cannabis…
…
continue reading
1
Streamlining the Process for Accessing Medical Marijuana Cards with Aspen Noonan Elevate Holistics
18:43
18:43
Play later
Play later
Lists
Like
Liked
18:43
Aspen Noonan, CEO of Elevate Holistics, a company that helps patients obtain medical marijuana cards through a telehealth consultation with licensed doctors. The qualifications for obtaining a medical marijuana card vary by state, and Elevate Holistics helps patients navigate the regulatory landscape. Many doctors are hesitant to recommend cannabis…
…
continue reading
1
Using AI-Powered Heart Monitors to Predict and Prevent AFib with Mark Goddard Infobionic.AI TRANSCRIPT
Mark Goddard, Vice President of Clinical Services at Infobionic.AI, describes the remote cardiac monitoring system that provides near real-time monitoring of patients with potential cardiac irregularities. The benefit of continuous monitoring allows for early detection of arrhythmias like atrial fibrillation, a growing concern driven by an aging po…
…
continue reading
1
Using AI-Powered Heart Monitors to Predict and Prevent AFib with Mark Goddard Infobionic.AI
20:53
20:53
Play later
Play later
Lists
Like
Liked
20:53
Mark Goddard, Vice President of Clinical Services at Infobionic.AI, describes the remote cardiac monitoring system that provides near real-time monitoring of patients with potential cardiac irregularities. The benefit of continuous monitoring allows for early detection of arrhythmias like atrial fibrillation, a growing concern driven by an aging po…
…
continue reading
Dr. Steven Quay, Chairman and CEO of Atossa Therapeutics, is dedicated to addressing unmet needs in breast cancer prevention and treatment. Dense breasts are a significant risk factor for breast cancer, and Atossa's lead drug candidate has shown effectiveness in reducing breast density and lowering the risk of cancer. This dual-action drug blocks e…
…
continue reading
1
Preventing Development of Breast Cancer with Dr. Steven Quay Atossa Therapeutics
21:15
21:15
Play later
Play later
Lists
Like
Liked
21:15
Dr. Steven Quay, Chairman and CEO of Atossa Therapeutics, is dedicated to addressing unmet needs in breast cancer prevention and treatment. Dense breasts are a significant risk factor for breast cancer, and Atossa's lead drug candidate has shown effectiveness in reducing breast density and lowering the risk of cancer. This dual-action drug blocks e…
…
continue reading
Dr. Alex Meves, distinguished dermatologist at the Mayo Clinic and a spokesperson for SkylineDx, discusses the challenges in diagnosing and treating melanoma and how a new molecular test called Merlin can help improve risk stratification and treatment decisions for patients with early-stage melanoma. Diagnosis and treatment have traditionally used …
…
continue reading
1
How Molecular Testing is Changing Melanoma Treatments with Dr. Alex Meves SkylineDx
18:00
18:00
Play later
Play later
Lists
Like
Liked
18:00
Dr. Alex Meves, distinguished dermatologist at the Mayo Clinic and a spokesperson for SkylineDx, discusses the challenges in diagnosing and treating melanoma and how a new molecular test called Merlin can help improve risk stratification and treatment decisions for patients with early-stage melanoma. Diagnosis and treatment have traditionally used …
…
continue reading
Elaina McMillan, a director of product marketing at Edifecs, describes the challenges and opportunities around healthcare data interoperability with a focus on prior authorization. Standardizing prior authorization workflows and data submissions across payers is a major focus to reduce delays and errors. Ensuring data security and patient consent a…
…
continue reading
1
How Interoperability is Breaking Down Healthcare Barriers with Elaina McMillan Edifecs
20:58
20:58
Play later
Play later
Lists
Like
Liked
20:58
Elaina McMillan, a director of product marketing at Edifecs, describes the challenges and opportunities around healthcare data interoperability with a focus on prior authorization. Standardizing prior authorization workflows and data submissions across payers is a major focus to reduce delays and errors. Ensuring data security and patient consent a…
…
continue reading
1
ReNEW Fund Creating Innovative Approach to Nursing Education with Anmy Mayfield Western Governors University TRANSCRIPT
Anmy Mayfield, Vice President and Dean for the Western Governors University College of Nursing in the Michael O. Leavitt School of Health, discusses the university's mission to provide accessible, online nursing education to address the nursing workforce shortage and encourage a more diverse population of nurses. The ReNEW Fund, a collaborative ini…
…
continue reading
1
ReNEW Fund Creating Innovative Approach to Nursing Education with Anmy Mayfield Western Governors University
20:55
20:55
Play later
Play later
Lists
Like
Liked
20:55
Anmy Mayfield, Vice President and Dean for the Western Governors University College of Nursing in the Michael O. Leavitt School of Health, discusses the university's mission to provide accessible, online nursing education to address the nursing workforce shortage and encourage a more diverse population of nurses. The ReNEW Fund, a collaborative ini…
…
continue reading
1
Nanoparticle Immunotherapy Reducing Cancer Recurrence Extending Survival Rates with Dr. Frank Bedu-Addo PDS Biotechnology TRANSCRIPT
Dr. Frank Bedu-Addo, President and CEO of PDS Biotechnology, focuses on the challenge of cancer recurrence and the development of a targeted immunotherapy approach using nanoparticle technology. Their lead immunotherapy candidate is designed to train the immune system to detect and attack microscopic or undetectable cancer cells, prolonging surviva…
…
continue reading
1
Nanoparticle Immunotherapy Reducing Cancer Recurrence Extending Survival Rates with Dr. Frank Bedu-Addo PDS Biotechnology
24:47
24:47
Play later
Play later
Lists
Like
Liked
24:47
Dr. Frank Bedu-Addo, President and CEO of PDS Biotechnology, focuses on the challenge of cancer recurrence and the development of a targeted immunotherapy approach using nanoparticle technology. Their lead immunotherapy candidate is designed to train the immune system to detect and attack microscopic or undetectable cancer cells, prolonging surviva…
…
continue reading
1
Developing Immunotherapy to Fight Bone Cancer with Paul Romness and Olivia Egge OS Therapies TRANSCRIPT
Paul Romness, Chairman, CEO, and President of OS Therapies, and Olivia Egge, a member of the Board of Directors of OS Therapies, discuss osteosarcoma, a rare and aggressive form of bone cancer that primarily affects teenagers. OS Therapies is developing an immunotherapy that utilizes a weakened form of the listeria bacteria to stimulate the immune …
…
continue reading
1
Developing Immunotherapy to Fight Bone Cancer with Paul Romness and Olivia Egge OS Therapies
19:05
19:05
Play later
Play later
Lists
Like
Liked
19:05
Paul Romness, Chairman, CEO, and President of OS Therapies, and Olivia Egge, a member of the Board of Directors of OS Therapies, discuss osteosarcoma, a rare and aggressive form of bone cancer that primarily affects teenagers. OS Therapies is developing an immunotherapy that utilizes a weakened form of the listeria bacteria to stimulate the immune …
…
continue reading
1
New Inhibitor Drug Transforms Cancer Treatment Accessibility with Dan Schmitt Actuate Therapeutics TRANSCRIPT
Dan Schmitt, President and CEO of Actuate Therapeutics, is developing a cancer therapy that inhibits GSK3β, a key enzyme that is hijacked in cancer cells to drive tumor growth. Inhibiting this enzyme can impact the cancer cells and stimulate an immune response against the tumor. Actuate selected metastatic pancreatic cancer as their first target du…
…
continue reading
1
New Inhibitor Drug Transforms Cancer Treatment Accessibility with Dan Schmitt Actuate Therapeutics
24:23
24:23
Play later
Play later
Lists
Like
Liked
24:23
Dan Schmitt, President and CEO of Actuate Therapeutics, is developing a cancer therapy that inhibits GSK3β, a key enzyme that is hijacked in cancer cells to drive tumor growth. Inhibiting this enzyme can impact the cancer cells and stimulate an immune response against the tumor. Actuate selected metastatic pancreatic cancer as their first target du…
…
continue reading
1
Democratizing Molecular Diagnostics Transforming Transplant Success with Andrea James iMDx TRANSCRIPT
Andrea James, Chief Financial Officer at iMDx, is focused on expanding access to innovative molecular diagnostic testing staring with a test for monitoring transplanted organ health. The test measures the donor-derived cell-free DNA which can indicate the need for drugs to target organ rejection before invasive procedures are required. The company …
…
continue reading
1
Democratizing Molecular Diagnostics Transforming Transplant Success with Andrea James iMDx
22:02
22:02
Play later
Play later
Lists
Like
Liked
22:02
Andrea James, Chief Financial Officer at iMDx, is focused on expanding access to innovative molecular diagnostic testing staring with a test for monitoring transplanted organ health. The test measures the donor-derived cell-free DNA which can indicate the need for drugs to target organ rejection before invasive procedures are required. The company …
…
continue reading
1
Healthcare Financial Recovery Driven by Focus on People First with James Hereford Fairview Health Services TRANSCRIPT
James Hereford, President and CEO of Fairview Health Services, describes this Minnesota-based healthcare system's $600 million turnaround and the importance of focusing on people and processes, not just technology changes. Addressing staff shortages, quality of care, and patient experience led to finding a holistic approach that improved financial …
…
continue reading
1
Healthcare Financial Recovery Driven by Focus on People First with James Hereford Fairview Health Services
21:46
21:46
Play later
Play later
Lists
Like
Liked
21:46
James Hereford, President and CEO of Fairview Health Services, describes this Minnesota-based healthcare system's $600 million turnaround and the importance of focusing on people and processes, not just technology changes. Addressing staff shortages, quality of care, and patient experience led to finding a holistic approach that improved financial …
…
continue reading
1
Innovative Homeostasis Focused Drugs to Treat Root Causes of Disease with Steve Butts Arrivo BioVentures TRANSCRIPT
teve Butts, Co-Founder and CEO of Arrivo BioVentures, is a biopharmaceutical company focused on developing therapies that target the root causes of disease rather than just treating the symptoms. Their drugs treat major depressive disorder and acute pancreatitis through novel epigenetic mechanisms of action. Sex-based differences were observed in c…
…
continue reading
